WO2009020458A1 - Msca1 nucleotide sequences impacting plant male fertility and method of using same - Google Patents
Msca1 nucleotide sequences impacting plant male fertility and method of using same Download PDFInfo
- Publication number
- WO2009020458A1 WO2009020458A1 PCT/US2007/075157 US2007075157W WO2009020458A1 WO 2009020458 A1 WO2009020458 A1 WO 2009020458A1 US 2007075157 W US2007075157 W US 2007075157W WO 2009020458 A1 WO2009020458 A1 WO 2009020458A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- nucleotide sequence
- gene
- sequence
- male
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/823—Reproductive tissue-specific promoters
- C12N15/8231—Male-specific, e.g. anther, tapetum, pollen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
- C12N15/8289—Male sterility
Definitions
- MSCA1 NUCLEOTIDE SEQUENCES IMPACTING PLANT MALE FERTILITY AND METHOD OF USING SAME
- Field crops are bred through techniques that take advantage of the plant's method of pollination.
- a plant is self-pollinating if pollen from one flower is transferred to the same or another flower of the same plant or a genetically identical plant.
- a plant is cross-pollinated if the pollen comes from a flower on a different plant.
- the plant In certain species, such as Brassica campest ⁇ s, the plant is normally self- sterile and can only be cross-pollinated. In self-pollinating species, such as soybeans and cotton, the male and female plants are anatomically juxtaposed. During natural pollination, the male reproductive organs of a given flower pollinate the female reproductive organs of the same flower.
- Maize plants (Zea mays L) present a unique situation in that they can be bred by both self-pollination and cross-pollination techniques. Maize has male flowers, located on the tassel, and female flowers, located on the ear, on the same plant. It can self or cross pollinate. Natural pollination occurs in maize when wind blows pollen from the tassels to the silks that protrude from the tops of the incipient ears. The development of maize hybrids requires the development of homozygous inbred lines, the crossing of these lines, and the evaluation of the crosses. Pedigree breeding and recurrent selection are two of the breeding methods used to develop inbred lines from populations.
- breeding programs combine desirable traits from two or more inbred lines or various broad-based sources into breeding pools from which new inbred lines are developed by selfing and selection of desired phenotypes.
- a hybrid maize variety is the cross of two such inbred lines, each of which may have one or more desirable characteristics lacked by the other or which complement the other. The new inbreds are crossed with other inbred lines and the hybrids from these crosses are evaluated to determine which have commercial potential.
- the hybrid progeny of the first generation is designated F ⁇
- Hybrid maize seed can be produced by a male sterility system incorporating manual detasseling.
- the male tassel is removed from the growing female inbred parent, which can be planted in various alternating row patterns with the male inbred parent. Consequently, providing that there is sufficient isolation from sources of foreign maize pollen, the ears of the female inbred will be fertilized only with pollen from the male inbred. The resulting seed is therefore hybrid (Fi) and will form hybrid plants.
- Field variation impacting plant development can result in plants tasseling after manual detasseling of the female parent is completed. Or, a female inbred plant tassel may not be completely removed during the detasseling process. In any event, the result is that the female plant will successfully shed pollen and some female plants will be self-pollinated. This will result in seed of the female inbred being harvested along with the hybrid seed which is normally produced. Female inbred seed does not exhibit heterosis and therefore is not as productive as Fi seed. In addition, the presence of female inbred seed can represent a germplasm security risk for the company producing the hybrid.
- the female inbred can be mechanically detasseled by machine.
- Mechanical detasseling is approximately as reliable as hand detasseling, but is faster and less costly.
- most detasseling machines produce more damage to the plants than hand detasseling.
- no form of detasseling is presently entirely satisfactory, and a need continues to exist for alternatives which further reduce production costs and to eliminate self-pollination of the female parent in the production of hybrid seed.
- CMS cytoplasmic male-sterile
- Fabijanski, et al. developed several methods of causing male sterility in plants (see EPO 89/3010153.8 publication no. 329,308 and PCT application PCT/CA90/00037 published as WO 90/08828).
- One method includes delivering into the plant a gene encoding a cytotoxic substance associated with a male tissue specific promoter.
- Fabijanski, et al. also shows several cytotoxic antisense systems. See EP0329308.
- a male sterility plant trait is expressed by maintenance of a homozygous recessive condition. Difficulties arise in maintaining the homozygous condition, when a restoration gene must be used for maintenance. For example, a natural mutation in a gene critical to male fertility can impart a male sterility phenotype to plants when this mutant allele is in the homozygous state. But because this homozygosity results in male sterility, the homozygous male-sterile line cannot be maintained. Fertility is restored when the non-mutant form of the gene is introduced into the plant.
- this form of line maintenance removes the desired homozygous recessive condition, restores full male fertility in half of the resulting progeny, and prevents maintenance of pure male sterile maternal lines.
- These issues can be avoided where production of pollen containing the restoration gene is eliminated, thus providing a maintainer plant producing only pollen not containing the restoration gene, and the progeny retain their homozygous condition when fertilized by such pollen.
- An example of one approach is shown in Dellaporta et al., 6,743,968, in which a plant is produced having a hemizygotic construct comprising a gene that produces a product fatal to a cell, linked with a pollen-specific promoter, and the restoration gene. When crossed with the homozygous recessive male sterile plant, the progeny thus retains the homozygous recessive condition.
- male sterility genes impacting male fertility.
- Such a gene can be used in a variety of systems to control male fertility including those described herein.
- Genetic male sterility results from a mutation, suppression, or other impact to one of the genes critical to a specific step in microsporogenesis, the term applied to the entire process of pollen formation. These genes can be collectively referred to as male fertility genes (or, alternatively, male sterility genes).
- male fertility genes or, alternatively, male sterility genes.
- genes that have been discovered subsequently that are critical to male fertility are numerous and include the Arabidopsis ABORTED MICROSPORES (AMS) gene, Sorensen et al., The Plant Journal (2003) 33(2):413-423); the Arabidopsis MS1 gene (Wilson et al., The Plant Journal (2001 ) 39(2):170-181 ); the NEF1 gene (Ahizumi et al., The Plant Journal ( 2004) 39(2):170-181 ); Arabidopsis AtGPATI gene (Zheng et al., The Plant Cell (2003) 15:1872-1887); the Arabdiopsis dde2-2 mutation was shown to be defective in the allene oxide syntase gene (Malek et al., Planta (2002)216:187-192); the Arabidopsis faceless pollen-1 gene (flp1 ) (Ariizumi et al, Plant MoI.
- AMS Arabidopsis ABORTED MICR
- the inventors provide novel DNA molecules and the amino acid sequence encoded that are critical to male fertility in plants. These can be used in any of the systems where control of fertility is useful, including those described above.
- one object of the invention is to provide a nucleic acid sequence, the expression of which is critical to male fertility in plants and in which a mutation of the sequence causes male sterility when in the homozygous state.
- Another object is to provide regulatory regions that preferentially direct expression of operably linked nucleotide sequences to male tissue(s) of a plant.
- a further object of the invention is to provide a method of using such nucleotide sequences to mediate male fertility in plants. Further objects of the invention will become apparent in the description and claims that follow.
- This invention relates to nucleic acid sequences, and, specifically, DNA molecules and the amino acid encoded by the DNA molecules, which are critical to male fertility. Impacting the functional expression of such sequences results in the mediation of male fertility. Regulatory regions directing expression preferentially to male tissue are also provided. The invention also relates to use of such nucleotide sequences to mediate fertility in plants.
- Figure 1 is a locus map of the male fertility gene Mscai.
- Figure 2 is the nucleotide sequence of the Mscai gene (SEQ ID NO: 1 )
- Figure 3 is the protein sequence of Mscai (SEQ ID NO: 2 )
- Figure 4 is the msca1-ref nucleotide sequence (SEQ ID NO: 3 )
- Figure 5 is an alignment of fertile and sterile msca1-mg12 alleles, (the nucleotide sequence of the fertile is SEQ ID NO: 4 ; the protein sequence is SEQ ID NO: 5; the nucleotide sequence of msca1-mg12 sterile is SEQ ID NO: 6 and the protein sequence is SEQ ID NO: 7).
- the fertile allele sequence contains an additional 490 base pairs deleted from the 3' region of the sterile sequence.
- Figure 6 shows alignment of the Mscai wildtype gene from the corn hybrid Missouri 17 (Mo17) (SEQ ID NO: 8)with msca1-mg12 alleles in a fertile plant (Mg12-Fert) (SEQ ID NO: 9)and a sterile plant (Mg12-Ster) (SEQ ID NO:10).
- the circled region refers to the CCMC redox motif (SEQ ID NO: 11 ) and the gluteredoxin binding site (GSH Binding) (SEQ ID NO: 12) is underlined.
- Figure 7 shows alignment of the mscai alleles, Ms22-6036 from a fertile plant (Fert) SEQ ID NO: 13) with a sterile plant ⁇ 6036s) (SEQ ID NO: 14).
- the sterile sequence contains an 850 base pair insertion at the 3' end.
- the insertion contains small perfect TIRs of eight basepairs (indicated at "TIR") with about 200 basepairs of a transposon-like sequence.
- Figure 8 shows a graphic alignment of the Mscai sequence with mutant alleles msca1-ref (, msca1-mg12 an ⁇ msca1-6036.
- Figure 9 is the full length promoter of Mscai (SEQ ID NO: 15)
- FigurelO is the nucleotide sequence of the rice Mscai gene (SEQ ID NO: 16)
- Figure 11 is the protein sequence of rice Mscai (SEQ ID NO: 17)
- Figure 12 is the full length promoter of rice Mscai (SEQ ID NO: 18)
- Figure 13 is the sequence of the rice mscai allele (SEQ ID NO: 19).
- any of the methods described infra can be used with the sequence of the invention such as introducing a mutant sequence into a plant to cause sterility, causing mutation to the native sequence, introducing an antisense of the sequence into the plant, use of hairpin formations, linking it with other sequences to control its expression, or any one of a myriad of processes available to one skilled in the art to impact male fertility in a plant.
- the Mscai gene (also referred to as Ms22) described herein is located on short arm of maize chromosome 7 and its dominant allele encodes a protein critical to male fertility.
- the locus map is represented at Figure 1.
- the Mscai gene can be used in the systems described above, and other systems impacting male fertility.
- ms22 or mscai were first noted as phenotypically male sterile with anthers did not exude from the tassel and lacked sporogenous tissue.
- the mutant locus was originally referred to as ms22 but was later changed to mscai, or male sterile converted anther. See Chaubal et al. "The transformation of anthers in the mscai mutant of maize" Planta (2003)216:778-788.
- Study of the mutant included collecting anthers from young spikelets of immature tassels in plant families segregating 1 :1 for male sterile/male fertility plants for microscopic study. Using an F 2 family segregating for the mscai mutation, DNA was isolated from male sterile plants, electrophoresed and hybridized with restriction fragment length polymorphism markers, and mapped to chromosome 7. See Chaubal et al. "The transformation of anthers in the mscai mutant of maize" Planta (2003)216:778-788.
- the mscai mutants are unusual in that stamen phmordia develop normally, but differentiation and cell division do not occur, with the tissue instead developing into nonfunctional vascular tissue. There is no asymmetric division of archesporial cells into large primary sporogenous and smaller primary parietal cells. Instead, the anther contains parenchymal cells and non-functional vascular strands with no formation of normal anther cells such as microspores, tapetum, middle layer and endothecium. All of the cell layers of the anther convert in mutant plants into vegetative structures. Since the Mscai gene operates after stamen primordial initiation and before division of the archesporial cells, interruption of gene expression acts as a developmental block.
- the invention is also directed to impacting male fertility of a plant by impacting the Mscai nucleotide sequence.
- Impacting male fertility refers to a change in the male fertility of the plant from the fertility phenotype prior to impacting the nucleotide sequence. It may result in male sterility, as when the sequence is impacted such that expression of the Mscai male fertility critical gene does not occur as in the wild-type condition.
- the fertility of a plant may also be impacted by, for example, introducing into a plant that comprises a mutated mscai allele, a Mscal nucleotide sequence which restores fertility.
- many variations are possible in impacting male fertility depending upon the specific application.
- the gene may contain an insertion, such as that shown in msca1-6036 allele, or have a deletion, such as with msca1-mg12 allele.
- Use of mutagenesis, antisense genes, co-suppression, hairpin formations, selecting for mutant plants, insertion of one or more additional sequences which act to disrupt the gene expression are a few examples of the many means available to interrupt expression of the Mscal gene.
- the invention is directed to restoring male fertility in a plant having expression of Mscal disrupted, by introducing into the plant the wild-type Mscal complementary sequence.
- a "functional fragment" of the Mscal sequence is a nucleotide sequence that is formed by one or more deletions from the entire sequence and which retains the functional of being critical for male fertility.
- One of ordinary skill in the art can readily assess the variant or fragment by its introduction into plants homozygous for a stable male sterile allele of Mscal, followed by observation of the plant's male tissue development.
- sequences of the invention may be isolated from any plant, including, but not limited to corn (Zea mays), canola ⁇ Brassica napus, Brassica rapa ssp.), alfalfa ⁇ Medicago sativa), rice ⁇ Oryza sativa), rye ⁇ Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), sunflower (Helianthus annuus), wheat
- Sequences from other plants may be isolated according to well-known techniques based on their sequence homology to the homologous coding region of the sequences set forth herein. In these techniques, all or part of the known coding sequence is used as a probe which selectively hybridizes to other sequences present in a population of cloned genomic DNA fragments (i.e. genomic libraries) from a chosen organism. Methods are readily available in the art for the hybridization of nucleic acid sequences. An extensive guide to the hybridization of nucleic acids is found in Tijssen, Laboratory Techniques in
- the invention also includes those nucleotide sequences which selectively hybridize to the Mscai nucleotide sequences under stringent conditions.
- sequence that "selectively hybridizes" with Mscai the term includes reference to hybridization, under stringent hybridization conditions, of a nucleic acid sequence to the specified nucleic acid target sequence to a detectably greater degree than its hybridization to non-target nucleic acid.
- stringent conditions or “stringent hybridization conditions” includes reference to conditions under which a probe will hybridize to its target sequence, to a detectably greater degree than to other sequences.
- Stringent conditions are target-sequence-dependent and will differ depending on the structure of the polynucleotide.
- target sequences can be identified which are 100% complementary to a probe (homologous probing).
- stringency conditions can be adjusted to allow some mismatching in sequences so that lower degrees of similarity are detected (heterologous probing).
- probes of this type are in a range of about 1000 nucleotides in length to about 250 nucleotides in length.
- sequences that correspond to the nucleotide sequences of the present invention and hybridize to the nucleotide sequence disclosed herein will be at least 50% homologous, 70% homologous, and even 85%, 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% homologous or more with the disclosed sequence. That is, the sequence similarity between probe and target may range, sharing at least about 50%, about 70%, and even about 85% or more sequence similarity.
- stringent wash temperature conditions are selected to be about 5°C to about 2°C lower than the melting point (Tm) for the specific sequence at a defined ionic strength and pH.
- Tm melting point
- the melting point, or denaturation, of DNA occurs over a narrow temperature range and represents the disruption of the double helix into its complementary single strands. The process is described by the temperature of the midpoint of transition, Tm, which is also called the melting temperature. Formulas are available in the art for the determination of melting temperatures.
- Preferred hybridization conditions for the nucleotide sequence of the invention include hybridization at 42 0 C in 50%(w/v) formamide, 6X SSC, 0.5%(w/v) SDS, 100(g/ml salmon sperm DNA.
- Exemplary low stringency washing conditions include hybridization at 42 0 C in a solution of 2X SSC, 0.5% (w/v) SDS for 30 minutes and repeating.
- Exemplary moderate stringency conditions include a wash in 2X SSC, 0.5% (w/v) SDS at 5O 0 C for 30 minutes and repeating.
- Exemplary high stringency conditions include a wash in 0.1 X SSC, 0.1 % (w/v) SDS, at 65 0 C for 30 minutes to one hour and repeating.
- Sequences that correspond to the promoter of the present invention may be obtained using all the above conditions.
- the high stringency conditions are used.
- the following terms are used to describe the sequence relationships between two or more nucleic acids or polynucleotides: (a) “reference sequence”, (b) “comparison window”, (c) “sequence identity”, and (d) “percentage of sequence identity.”
- reference sequence is a defined sequence used as a basis for sequence comparison.
- a reference sequence may be a subset or the entirety of a specified sequence; for example, as a segment of a full-length cDNA or gene sequence, or the complete cDNA or gene sequence.
- comparison window makes reference to a contiguous and specified segment of a polynucleotide sequence, wherein the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences.
- the comparison window is at least 20 contiguous nucleotides in length, and optionally can be 30, 40, 50, or 100 nucleotides in length, or longer.
- Computer implementations of these mathematical algorithms can be utilized for comparison of sequences to determine sequence identity. Such implementations include, but are not limited to: CLUSTAL in the PC/Gene program (available from Intelligenetics, Mountain View, California); the ALIGN program (Version 2.0) and GAP, BESTFIT, BLAST, FASTA, and TFASTA in the GCG Wisconsin Genetics Software Package, Version 10 (available from Accelrys Inc., 9685 Scranton Road, San Diego, California, USA). Alignments using these programs can be performed using the default parameters.
- CLUSTAL program is well described by Higgins et al. (1988) Gene 73: 237-244 (1988); Higgins et al.
- Gapped BLAST in BLAST 2.0
- PSI-BLAST in BLAST 2.0
- PSI-BLAST in BLAST 2.0
- sequence identity/similarity values provided herein refer to the value obtained using GAP Version 10 using the following parameters: % identity and % similarity for a nucleotide sequence using GAP Weight of 50 and Length Weight of 3 and the nwsgapdna.cmp scoring matrix; % identity and % similarity for an amino acid sequence using GAP Weight of 8 and Length Weight of 2; and the BLOSUM62 scoring matrix or any equivalent program thereof.
- equivalent program is intended any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide or amino acid residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by GAP Version 10.
- GAP uses the algorithm of Needleman and Wunsch (1970) J. MoI. Biol. 48: 443-453, to find the alignment of two complete sequences that maximizes the number of matches and minimizes the number of gaps. GAP considers all possible alignments and gap positions and creates the alignment with the largest number of matched bases and the fewest gaps. It allows for the provision of a gap creation penalty and a gap extension penalty in units of matched bases. GAP must make a profit of gap creation penalty number of matches for each gap it inserts. If a gap extension penalty greater than zero is chosen, GAP must, in addition, make a profit for each gap inserted of the length of the gap times the gap extension penalty.
- gap creation penalty values and gap extension penalty values in Version 10 of the GCG Wisconsin Genetics Software Package for protein sequences are 8 and 2, respectively.
- the default gap creation penalty is 50 while the default gap extension penalty is 3.
- the gap creation and gap extension penalties can be expressed as an integer selected from the group of integers consisting of from 0 to 200.
- the gap creation and gap extension penalties can be 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65 or greater.
- GAP presents one member of the family of best alignments. There may be many members of this family, but no other member has a better quality. GAP displays four figures of merit for alignments: Quality, Ratio, Identity, and Similarity.
- the Quality is the metric maximized in order to align the sequences. Ratio is the quality divided by the number of bases in the shorter segment. Percent Identity is the percent of the symbols that actually match. Percent Similarity is the percent of the symbols that are similar. Symbols that are across from gaps are ignored. A similarity is scored when the scoring matrix value for a pair of symbols is greater than or equal to 0.50, the similarity threshold.
- the scoring matrix used in Version 10 of the GCG Wisconsin Genetics Software Package is BLOSUM62 (see Henikoff and Henikoff (1989) Proc. Natl. Acad. Sci. USA 89:10915).
- sequence identity or “identity” in the context of two nucleic acid or polypeptide sequences makes reference to the residues in the two sequences that are the same when aligned for maximum correspondence over a specified comparison window.
- percentage of sequence identity is used in reference to proteins it is recognized that residue positions which are not identical often differ by conservative amino acid substitutions, where amino acid residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule.
- sequences differ in conservative substitutions the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution.
- Sequences that differ by such conservative substitutions are said to have "sequence similarity" or "similarity”. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated, e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, California).
- percentage of sequence identity means the value determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison, and multiplying the result by 100 to yield the percentage of sequence identity.
- polynucleotide is not intended to limit the present invention to polynucleotides comprising DNA.
- polynucleotides can comprise ribonucleotides and combinations of ribonucleotides and deoxyribonucleotides. Such deoxyhbonucleotides and ribonucleotides include both naturally occurring molecules and synthetic analogues.
- the polynucleotides of the invention also encompass all forms of sequences including, but not limited to, single-stranded forms, double-stranded forms, hairpins, stem-and-loop structures, and the like.
- Identity to the sequence of the present invention would mean a polynucleotide sequence having at least 65% sequence identity, more preferably at least 70% sequence identity, more preferably at least 75% sequence identity, more preferably at least 80% identity, more preferably at least 85% 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity.
- the promoter of the Mscai gene is also the subject of the present invention, as shown in the 1132 base pair sequence of Figure 9 (SEQ ID NO: 15).
- the regulatory region of the gene comprises bases 1 to 1132 of Figure 9, SEQ ID NO: 15 and other functional fragments of same. Promoter regions can be readily identified by one skilled in the art.
- the putative start codon containing the ATG motif is identified at base 1133 of SEQ ID NO: 1 ( See Figure 2) and upstream from the start codon is the presumptive promoter.
- promoter is intended a regulatory region of DNA usually comprising a
- a promoter capable of directing RNA polymerase Il to initiate RNA synthesis at the appropriate transcription initiation site for a particular coding sequence.
- a promoter can additionally comprise other recognition sequences generally positioned upstream or 5' to the TATA box, referred to as upstream promoter elements, which influence the transcription initiation rate. It is recognized that having identified the nucleotide sequences for the promoter region disclosed herein, it is within the state of the art to isolate and identify further regulatory elements in the region upstream of the TATA box from the particular promoter region identified herein. Thus the promoter region disclosed herein is generally further defined by comprising upstream regulatory elements such as those responsible for tissue and temporal expression of the coding sequence, enhancers and the like.
- the promoter elements which enable expression in the desired tissue such as male tissue can be identified, isolated, and used with other core promoters to confirm male tissue-preferred expression.
- core promoter is meant the minimal sequence required to initiate transcription, such as the sequence called the TATA box which is common to promoters in genes encoding proteins.
- the upstream promoter of Mscai can optionally be used in conjunction with its own or core promoters from other sources.
- the promoter may be native or non-native to the cell in which it is found.
- a putative TATA box can be identified by primer extension analysis as described in by Current Protocols in Molecular Biology, Ausubel, F. M. et al.
- Regulatory regions of anther genes may be identified in genomic subclones using functional analysis, usually verified by the observation of reporter gene expression in anther tissue and a lower level or absence of reporter gene expression in non-anther tissue. The possibility of the regulatory regions residing "upstream" or 5' ward of the translational start site can be tested by subcloning a DNA fragment that contains the upstream region into expression vectors for transient expression experiments. It is expected that smaller subgenomic fragments may contain the regions essential for male-tissue preferred expression.
- the essential regions of the CaMV 19S and 35S promoters have been identified in relatively small fragments derived from larger genomic pieces as described in U.S. Pat. No. 5,352,605.
- the selection of an appropriate expression vector with which to test for functional expression will depend upon the host and the method of introducing the expression vector into the host and such methods are well known to one skilled in the art.
- the regions in the vector include regions that control initiation of transcription and control processing. These regions are operably linked to a reporter gene such as CYP, UidA, encoding glucuronidase (GUS), or luciferase as described herein.
- Expression vectors containing putative regulatory regions located in genomic fragments can be introduced into intact tissues such as staged anthers, embryos or into callus. Methods of DNA delivery are described below. For the transient assay system, various analysis may be employed. In one example, staged, isolated anthers are immediately placed onto tassel culture medium (Pareddy, D. R. and J. F. Petelino, Crop Sci. J.; Vol. 29; pp. 1564-1566; (1989)) solidified with 0.5% Phytagel (Sigma, St. Louis) or other solidifying media. The expression vector DNA is introduced within 5 hours preferably by microprojectile-mediated delivery with 1.2 ⁇ m particles at 1000 -1100 Psi.
- the anthers are incubated at 26 0 C upon the same tassel culture medium for 17 hours and analyzed by preparing a whole tissue homogenate and assaying for GUS or for lucifierase activity (see Gruber, et al., supra).
- the isolated promoter sequence of the present invention can be modified to provide for a range of expression levels of the heterologous nucleotide sequence. Less than the entire promoter region can be utilized and the ability to drive anther- preferred expression retained. However, it is recognized that expression levels of mRNA can be decreased with deletions of portions of the promoter sequence. Thus, the promoter can be modified to be a weak or strong promoter. Generally, by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended levels of about 1/10,000 transcripts to about 1/100,000 transcripts to about 1/500,000 transcripts.
- a strong promoter drives expression of a coding sequence at a high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1 ,000 transcripts.
- at least about 30 nucleotides of an isolated promoter sequence will be used to drive expression of a nucleotide sequence.
- enhancers can be utilized in combination with the promoter regions of the invention. Enhancers are nucleotide sequences that act to increase the expression of a promoter region. Enhancers are known in the art and include the SV40 enhancer region, the 35S enhancer element, and the like.
- the promoter of the present invention can be isolated from the 5' region of its native coding region or 5' untranslated region (5'UTR). Likewise the terminator can be isolated from the 3' region flanking its respective stop codon.
- isolated refers to material such as a nucleic acid or protein which is substantially or essentially free from components which normally accompany or interact with the material as found in it naturally occurring environment, or if the material is in its natural environment, the material has been altered by deliberate human intervention to a composition and/or placed at a locus in a cell other than the locus native to the material. Methods for isolation of promoter regions are well known in the art.
- Functional variants include, for example, the native regulatory sequences of the invention having one or more nucleotide substitutions, deletions or insertions. Functional variants of the invention may be created by site-directed mutagenesis, induced mutation, or may occur as allelic variants (polymorphisms).
- a "functional fragment" of the regulatory sequence is a nucleotide sequence that is a regulatory sequence variant formed by one or more deletions from a larger sequence.
- the 5' portion of a promoter up to the TATA box near the transcription start site can be deleted without abolishing promoter activity, as described by Opsahl-Sorteberg, H-G. et al., "Identification of a 49-bp fragment of the HvLTP2 promoter directing aleruone cell specific expression” Gene 341 :49-58 (2004).
- Such variants should retain promoter activity, particularly the ability to drive expression in male tissues. Activity can be measured by Northern blot analysis, reporter activity measurements when using transcriptional fusions, and the like. See, for example, Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N. Y.), herein incorporated by reference.
- Functional fragments can be obtained by use of restriction enzymes to cleave the naturally occurring regulatory element nucleotide sequences disclosed herein; by synthesizing a nucleotide sequence from the naturally occurring DNA sequence; or can be obtained through the use of PCR technology See particularly, Mullis et al. (1987) Methods Enzymol. 155:335-350, and Erlich, ed. (1989) PCR Technology (Stockton Press, New York).
- Sequences which hybridize to the regulatory sequences of the present invention are within the scope of the invention. Sequences that correspond to the promoter sequences of the present invention and hybridize to the promoter sequences disclosed herein will be at least 50% homologous, 70% homologous, and even 85% 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% homologous or more with the disclosed sequence.
- Smaller fragments may yet contain the regulatory properties of the promoter so identified and deletion analysis is one method of identifying essential regions.
- Deletion analysis can occur from both the 5' and 3' ends of the regulatory region. Fragments can be obtained by site-directed mutagenesis, mutagenesis using the polymerase chain reaction and the like. (See, Directed Mutagenesis: A Practical Approach IRL Press (1991 )).
- the 3' deletions can delineate the essential region and identify the 3' end so that this region may then be operably linked to a core promoter of choice.
- transcription of an exogenous gene may be controlled by the essential region plus a core promoter.
- core promoter is meant the sequence called the TATA box which is common to promoters in all genes encoding proteins.
- the upstream promoter of Mscai can optionally be used in conjunction with its own or core promoters from other sources.
- the promoter may be native or non-native to the cell in which it is found.
- the core promoter can be any one of known core promoters such as the Cauliflower Mosaic Virus 35S or 19S promoter (U.S. Patent No. 5,352,605), ubiquitin promoter (U.S. Patent No. 5,510,474) the IN2 core promoter (U.S. Patent No. 5,364,780) or a Figwort Mosaic Virus promoter (Gruber, et al. "Vectors for Plant Transformation” Methods in Plant Molecular Biology and Biotechnology ) et al. eds, CRC Press pp.89-119 (1993)).
- core promoters such as the Cauliflower Mosaic Virus 35S or 19S promoter (U.S. Patent No. 5,352,605), ubiquitin promoter (U.S. Patent No. 5,510,474) the IN2 core promoter (U.S. Patent No. 5,364,780) or a Figwort Mosaic Virus promoter (Gruber, et al.
- Promoter sequences from other plants may be isolated according to well- known techniques based on their sequence homology to the promoter sequence set forth herein. In these techniques, all or part of the known promoter sequence is used as a probe which selectively hybridizes to other sequences present in a population of cloned genomic DNA fragments (i.e. genomic libraries) from a chosen organism. Methods are readily available in the art for the hybridization of nucleic acid sequences.
- the entire promoter sequence or portions thereof can be used as a probe capable of specifically hybridizing to corresponding promoter sequences.
- probes include sequences that are unique and are preferably at least about 10 nucleotides in length, and most preferably at least about 20 nucleotides in length.
- Such probes can be used to amplify corresponding promoter sequences from a chosen organism by the well-known process of polymerase chain reaction (PCR). This technique can be used to isolate additional promoter sequences from a desired organism or as a diagnostic assay to determine the presence of the promoter sequence in an organism. Examples include hybridization screening of plated DNA libraries (either plaques or colonies; see e.g. lnnis et al., eds., (1990) PCR Protocols, A Guide to Methods and Applications, Academic Press).
- a promoter of the present invention can be linked with nucleotide sequences other than the Mscai gene to express other heterologous nucleotide sequences.
- the nucleotide sequence for the promoter of the invention, as well as fragments and variants thereof, can be provided in expression cassettes along with heterologous nucleotide sequences for expression in the plant of interest, more particularly in the male tissue of the plant.
- Such an expression cassette is provided with a plurality of restriction sites for insertion of the nucleotide sequence to be under the transcriptional regulation of the promoter.
- nucleotide sequences which can be used as the exogenous gene of the expression vector with the Mscai promoter, or other promoters taught herein or known to those of skill in the art include complementary nucleotidic units such as antisense molecules (callase antisense RNA, barnase antisense RNA and chalcone synthase antisense RNA, Ms45 antisense RNA), hbozymes and external guide sequences, an aptamer or single stranded nucleotides.
- antisense molecules callase antisense RNA, barnase antisense RNA and chalcone synthase antisense RNA, Ms45 antisense RNA
- hbozymes and external guide sequences
- external guide sequences an aptamer or single stranded nucleotides.
- the exogenous nucleotide sequence can also encode carbohydrate degrading or modifying enzymes, amylases, debranching enzymes and pectinases, such as the alpha amylase gene, auxins, rol B, cytotoxins, diptheria toxin, DAM methylase, avid in, or may be selected from a prokaryotic regulatory system.
- carbohydrate degrading or modifying enzymes such as the alpha amylase gene, auxins, rol B, cytotoxins, diptheria toxin, DAM methylase, avid in, or may be selected from a prokaryotic regulatory system.
- barnase an RNase of Bacillus amyloliquefaciens
- Quaas, et al., Eur. J. Biochem. Vol. 173: pp. 617 (1988) describe the chemical synthesis of the RNase-T1 , while the nucleotide sequence of the barnase gene is disclosed in Hartley, J. Molec. Biol.; Vol. 202: pp. 913 (1988).
- the rolB gene of Agrobacterium rhizogenes codes for an enzyme that interferes with auxin metabolism by catalyzing the release of free indoles from indoxyl- ⁇ -glucosides.
- Estruch, et al., EMBO J. Vol. 11 : pp. 3125 (1991 ) and Spena, et al., Theor. Appl. Genet; Vol. 84: pp. 520 (1992) have shown that the anther-specific expression of the rolB gene in tobacco resulted in plants having shriveled anthers in which pollen production was severely decreased and the rolB gene is an example of a gene that is useful for the control of pollen production. Slightom, et al., J.
- DNA molecules encoding the diphtheria toxin gene can be obtained from the American Type Culture Collection (Rockville, MD), ATCC No. 39359 or ATCC No. 67011 and see Fabijanski, et al., EP. Appl. No. 90902754.2, "Molecular Methods of Hybrid Seed Production" for examples and methods of use.
- the DAM methylase gene is used to cause sterility in the methods discussed at U.S. Patent No. 5,689,049 and PCT/US95/15229 Cigan, A.M.
- the invention includes vectors with the Mscai gene and/or its promoter.
- a vector is prepared comprising Mscai, a promoter that will drive expression of the gene in the plant and a terminator region.
- the promoter in the construct may be the native promoter or a substituted promoter which will provide expression in the plant.
- the promoter in the construct may be an inducible promoter, so that expression of the sense or antisense molecule in the construct can be controlled by exposure to the inducer.
- a plant-compatible promoter element can be employed in the construct, influenced by the end result desired.
- the promoter drive expression of the sequence sufficiently early in plant development that the Mscai sequence or fragment or variant is expressed after primordial initiation but before division of archesporial cells.
- the variety of promoters include the constitutive viral promoters such as the cauliflower mosaic virus (CaMV) 19S and 35S promoters or the figwort mosaic virus 35S promoter. See Kay et al., (1987) Science 236:1299 and European patent application No.
- ubiquitin promoter see for example US patent 5,510,474 or any other ubiquitin- like promoter, which encodes a ubiquitin protein, but may have varying particular sequences (for example US Patents 5,614,399 and 6,054,574).
- the construct can also contain one of the variety of other promoters available, depending upon the particular application.
- the promoter may be linked with a selectable marker, or a gene of interest for expression in the plant cell.
- any plant- compatible promoter can be employed.
- Those can be the 35S and ubiquitin-like promoters as referred to above, or any other plant gene promoters, such as, for example, the promoter for the small subunit of hbulose-1 ,5-bis-phosphate carboxylase, or promoters from the tumor-inducing plasmids from Agrobacterium tumefaciens, such as the nopal ine synthase and octopine synthase promoters; the barley lipid transfer protein promoter, LTP2 (KaIIa et al., Plant J. (1994) 6(6): 849-60); the END2 promoter (Linnestad et al.
- the promoter for the small subunit of hbulose-1 ,5-bis-phosphate carboxylase or promoters from the tumor-inducing plasmids from Agrobacterium tumefaciens, such as the nopal ine synthase and octopine synthase promoters
- the range of available plant compatible promoters includes tissue specific and inducible promoters.
- An inducible regulatory element is one that is capable of directly or indirectly activating transcription of one or more DNA sequences or genes in response to an inducer. In the absence of an inducer the DNA sequences or genes will not be transcribed.
- the protein factor that binds specifically to an inducible regulatory element to activate transcription is present in an inactive form which is then directly or indirectly converted to the active form by the inducer.
- the inducer can be a chemical agent such as a protein, metabolite, growth regulator, herbicide or phenolic compound or a physiological stress imposed directly by heat, cold, salt, or toxic elements or indirectly through the action of a pathogen or disease agent such as a virus.
- a plant cell containing an inducible regulatory element may be exposed to an inducer by externally applying the inducer to the cell or plant such as by spraying, watering, heating or similar methods.
- any inducible promoter can be used in the instant invention. See Ward et al. Plant MoI. Biol. 22: 361 -366 (1993).
- Exemplary inducible promoters include ecdysone receptor promoters, U.S. Patent No. 6,504,082; promoters from the ACE1 system which responds to copper (Mett et al. PNAS 90: 4567-4571 (1993)); In2-1 and In2- 2 gene from maize which respond to benzenesulfonamide herbicide safeners (U.S. Patent No. 5,364,780; Hershey et al., MoI. Gen. Genetics 227: 229-237 (1991 ) and Gatz et al., MoI. Gen.
- promoters of interest include steroid-responsive promoters (see, for example, the glucocorticoid-inducible promoter in Schena et al. (1991 ) Proc. Natl. Acad. Sci. USA 88:10421-10425 and McNeINs et al. (1998) Plant J.
- Tissue-preferred promoters can be utilized to target enhanced transcription and/or expression within a particular plant tissue. Promoters may express in the tissue of interest, along with expression in other plant tissue, may express strongly in the tissue of interest and to a much lesser degree than other tissue, or may express highly preferably in the tissue of interest. Tissue-preferred promoters include those described in Yamamoto et al. (1997) Plant J. 12(2): 255-265; Kawamata et al. (1997) Plant Cell Physiol. 38(7): 792-803; Hansen et al. (1997) MoI. Gen Genet. 254(3):337-343; Russell et al. (1997) Transgenic Res. 6(2): 157- 168; Rinehart et al. (1996) Plant Physiol.
- the promoters are those which preferentially express to the male or female tissue of the plant.
- the invention does not require that any particular male tissue-preferred promoter be used in the process, and any of the many such promoters known to one skilled in the art may be employed.
- the native Mscai promoter described herein is one example of a useful promoter.
- Another such promoter is the 5126 promoter, which preferentially directs expression of the gene to which it is linked to male tissue of the plants, as described in U.S. Patents Nos. 5,837,851 and 5,689,051.
- Other examples include the Ms45 promoter described at US Patent No. 6,037,523; Ms26 promoter described at US Publication No.
- Certain constructs may also include a gamete tissue preferred promoter, depending upon the various components and the applications in which it is employed.
- Male gamete preferred promoters include the PG47 promoter, supra as well as ZM 13 promoter (Hamilton et al., Plant MoI. Biol. (1998) 38:663-669); actin depolymerizing factor promoters (such as Zmabpi , Zmabp2; see for example Lopez et al. Proc. Natl. Acad. Sci. USA (1996) 93: 7415-7420); the promoter of the maize petctin methylesterase-liked gene, ZmC5 ( Wakeley et al. Plant MoI. Biol.
- vectors may be included, also depending upon intended use of the gene. Examples include selectable markers, targeting or regulatory sequences, stabilizing or leader sequences, introns etc.
- General descriptions and examples of plant expression vectors and reporter genes can be found in Gruber, et al., "Vectors for Plant Transformation” in Method in Plant Molecular Biology and Biotechnology, Glick et al eds;CRC Press pp. 89-119 (1993). The selection of an appropriate expression vector will depend upon the host and the method of introducing the expression vector into the host.
- the expression cassette will also include at the 3' terminus of the heterologous nucleotide sequence of interest, a transcriptional and translational termination region functional in plants.
- the termination region can be native with the promoter nucleotide sequence of the present invention, can be native with the DNA sequence of interest, or can be derived from another source.
- Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also, Guerineau et al. MoI. Gen. Genet. 262:141 -144 (1991 ); Proudfoot, Ce// 64:671- 674 (1991 ); Sanfacon et al. Genes Dev. 5:141 -149 (1991 ); Mogen et al. Plant Cell 2:1261 -1272 (1990); Munroe et al. Gene 91 :151 -158 (1990); Ballas et al. Nucleic Acids Res. 17:7891-7903 (1989); Joshi et al. Nucleic Acid Res. 15:9627-9639 (1987).
- the expression cassettes can additionally contain 5' leader sequences.
- leader sequences can act to enhance translation.
- Translation leaders are known in the art and include by way of example, picornavirus leaders, EMCV leader (Encephalomyocarditis 5' noncoding region), Elroy-Stein et al. Proc. Nat. Acad. Sci. USA 86:6126-6130 (1989); potyvirus leaders, for example, TEV leader (Tobacco Etch Virus), Allison et al.; MDMV leader (Maize Dwarf Mosaic Virus), V/ro/ogy 154:9-20 (1986); human immunoglobulin heavy-chain binding protein (BiP), Macejak et al.
- EMCV leader Engelphalomyocarditis 5' noncoding region
- potyvirus leaders for example, TEV leader (Tobacco Etch Virus), Allison et al.; MDMV leader (Maize Dwarf Mosaic Virus), V/ro/ogy 154:9
- the expression cassette can further comprise a coding sequence for a transit peptide.
- transit peptides are well known in the art and include, but are not limited to, the transit peptide for the acyl carrier protein, the small subunit of RUBISCO, plant EPSP synthase, Zea mays Brittle-1 chloroplast transit peptide (Nelson et al. Plant physiol 117(4): 1235-1252 (1998); Sullivan et al.
- the various DNA fragments can be manipulated, so as to provide for the DNA sequences in the proper orientation and, as appropriate, in the proper reading frame.
- adapters or linkers can be employed to join the DNA fragments or other manipulations can be involved to provide for convenient restriction sites, removal of superfluous DNA, removal of restriction sites, or the like.
- in vitro mutagenesis, primer repair, restriction digests, annealing, and resubstitutions, such as transitions and transversions can be involved.
- the present invention provides vectors capable of expressing genes of interest.
- the vectors should be functional in plant cells.
- Vectors and procedures for cloning and expression in E. coli are discussed in Sambrook et al. (supra).
- the transformation vector comprising the promoter sequence of the present invention, or another promoter operably linked to a heterologous nucleotide sequence in an expression cassette and/or the nucleotide sequence of the present invention, can also contain at least one additional nucleotide sequence for a gene to be cotransformed into the organism. Alternatively, the additional sequence(s) can be provided on another transformation vector.
- Reporter genes can be included in the transformation vectors. Examples of suitable reporter genes known in the art can be found in, for example, Jefferson et al. (1991 ) in Plant Molecular Biology Manual, ed. Gelvin et al. (Kluwer Academic Publishers), pp. 1-33; DeWet et al. MoI. Cell. Biol. 7:725-737 (1987); Goff et al. EMBO J. 9:2517-2522 (1990); Kain et al. BioTechniques 19:650-655 (1995); and Chiu et al. Current Biology 6:325-330 (1996).
- Selectable reporter genes for selection of transformed cells or tissues can be included in the transformation vectors. These can include genes that confer antibiotic resistance or resistance to herbicides. Examples of suitable selectable marker genes include, but are not limited to, genes encoding resistance to chloramphenicol, Herrera Estrella et al. EMBO J. 2:987-992(1983); methotrexate, Herrera Estrella et al. Nature 303:209-213(1983); Meijer et al. Plant MoI. Biol. 16:807-820 (1991 ); hygromycin, Waldron et al. Plant MoI. Biol. 5:103-108 (1985), Zhijian et al.
- Scorable or screenable markers may also be employed, where presence of the sequence produces a measurable product.
- examples include a ⁇ - glucuronidase, or uidA gene (GUS), which encodes an enzyme for which various chromogenic substrates are known (for example, US Patents 5,268,463 and 5,599,670); chloramphenicol acetyl transferase (Jefferson et al. The EMBO Journal vol. 6 No. 13 pp. 3901 -3907); and alkaline phosphatase.
- GUS uidA gene
- anthocyanin/flavonoid genes in general (See discussion at Taylor and Briggs, The Plant Cell (1990)2:115-127) including, for example, a R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues (Dellaporta et al., in Chromosome Structure and Function, Kluwer Academic Publishers, Appels and Gustafson eds., pp. 263-282 (1988)); the genes which control biosynthesis of flavonoid pigments, such as the maize C1 gene (Kao et al., Plant Cell (1996) 8: 1171 -1179; Scheffler et al. MoI. Gen. Genet.
- Suitable markers include the cyan fluorescent protein (CYP) gene (Bolte et al. (2004) J. Cell Science 117: 943- 54 and Kato et al. (2002) Plant Physiol 129: 913-42), the yellow fluorescent protein gene (PhiYFPTM from Evrogen; see Bolte et al. (2004) J.
- CYP cyan fluorescent protein
- a lux gene which encodes a luciferase, the presence of which may be detected using, for example, X-ray film, scintillation counting, fluorescent spectrophotometry, low-light video cameras, photon counting cameras or multiwell luminometry (Teeri et al. (1989) EMBO J. 8:343); a green fluorescent protein (GFP) gene (Sheen et al., Plant J. (1995) 8(5):777-84); and DsRed2 where plant cells transformed with the marker gene are red in color, and thus visually selectable (Dietrich et al. (2002) Biotechniques 2(2):286-293).
- GFP green fluorescent protein
- Additional examples include a p-lactamase gene (Sutcliffe, Proc. Nat'l. Acad. Sci. U.S.A. (1978) 75:3737), which encodes an enzyme for which various chromogenic substrates are known (e.g., PADAC, a chromogenic cephalosporin); a xylE gene (Zukowsky et al., Proc. Nat'l. Acad. Sci. U.S.A. (1983) 80:1101 ), which encodes a catechol dioxygenase that can convert chromogenic catechols; an ⁇ -amylase gene (Ikuta et al., Biotech.
- transformation/transfection is not critical to the instant invention; various methods of transformation or transfection are currently available. As newer methods are available to transform crops or other host cells they may be directly applied. Accordingly, a wide variety of methods have been developed to insert a DNA sequence into the genome of a host cell to obtain the transcription or transcript and translation of the sequence to effect phenotypic changes in the organism. Thus, any method which provides for efficient transformation/transfection may be employed.
- Methods for introducing expression vectors into plant tissue available to one skilled in the art are varied and will depend on the plant selected. Procedures for transforming a wide variety of plant species are well known and described throughout the literature. See, for example, Miki et al, "Procedures for Introducing Foreign DNA into Plants” in Methods in Plant Molecular Biotechnology, supra; Klein et al, Bio/Technology 10:268 (1992); and Weising et al., Ann. Rev. Genet. 22: 421 -477 (1988).
- the DNA construct may be introduced into the genomic DNA of the plant cell using techniques such as microprojectile-mediated delivery, Klein et al., Nature 327: 70-73 (1987); electroporation, Fromm et al., Proc.
- Rice transformation is described by Hiei et al., "Efficient Transformation of Rice (Oryza sativs L) Mediated by Agrobacterium and Sequence Analysis of the Boundaries of the T-DNA" The Plant Journal 6(2): 271 -282 (1994, Christou et al, Trends in Biotechnology 10:239 (1992) and Lee et al, Proc. Nat'l Acad. Sci. USA 88:6389 (1991 ). Wheat can be transformed by techniques similar to those used for transforming corn or rice. Sorghum transformation is described at Casas et al, supra and sorghum by Wan et al, Plant Physicol. 104:37 (1994).
- Soybean transformation is described in a number of publications, including U.S. Patent No. 5,015,580.
- introduction of the nucleotide sequence into a plant, it is meant that this can occur by direct transformation methods, such as Agrobacterium transformation of plant tissue, microprojectile bombardment, electroporation, or any one of many methods known to one skilled in the art; or, it can occur by crossing a plant having the heterologous nucleotide sequence with another plant so that progeny have the nucleotide sequence incorporated into their genomes.
- direct transformation methods such as Agrobacterium transformation of plant tissue, microprojectile bombardment, electroporation, or any one of many methods known to one skilled in the art.
- crossing such as Agrobacterium transformation of plant tissue, microprojectile bombardment, electroporation, or any one of many methods known to one skilled in the art
- progeny have the nucleotide sequence incorporated into their genomes.
- Backcrossing methods may be used to introduce a gene into the plants. This technique has been used for decades to introduce traits into a plant. An example of a description of this and other plant breeding methodologies that are well known can be found in references such as Plant Breeding Methodology, edit. Neal Jensen, John Wiley & Sons, Inc. (1988). In a typical backcross protocol, the original variety of interest (recurrent parent) is crossed to a second variety (nonrecurrent parent) that carries the single gene of interest to be transferred.
- the resulting progeny from this cross are then crossed again to the recurrent parent and the process is repeated until a plant is obtained wherein essentially all of the desired morphological and physiological characteristics of the recurrent parent are recovered in the converted plant, in addition to the single transferred gene from the nonrecurrent parent.
- Homozygosity is a genetic condition existing when identical alleles reside at corresponding loci on homologous chromosomes.
- Heterozygosity is a genetic condition existing when different alleles reside at corresponding loci on homologous chromosomes. Hemizygosity is a genetic condition existing when there is only one copy of a gene (or set of genes) with no allelic counterpart on the sister chromosome.
- the homozygous recessive condition results in conferring on the plant a trait of interest, which can be any trait desired and which results from the recessive genotype, such as increased drought or cold tolerance, early maturity, changed oil or protein content, or any of a multitude of the many traits of interest to plant breeders.
- the homozygous recessive condition confers male sterility upon the plant.
- the sequence which is the functional complement of the homozygous condition is introduced into the plant (that is, a sequence which, when introduced into and expressed in the plant having the homozygous recessive condition, restores the wild-type condition)
- fertility is restored by virtue of restoration of the wild-type fertile phenotype.
- Maintenance of the homozygous recessive condition is achieved by introducing into a plant restoration transgene construct into a plant that is linked to a sequence which interferes with the function or formation of male gametes of the plant to create a maintainer or donor plant.
- transgene upon introduction into a plant that is homozygous recessive for the genetic trait, restores the genetic function of that trait, with the plant producing only viable pollen containing a copy of the recessive allele but not containing the restoration transgene.
- the transgene is kept in the hemizygous state in the maintainer plant.
- transgene it is meant any nucleic acid sequence which is introduced into the genome of a cell by genetic engineering techniques.
- a transgene may be a native DNA sequence, or a heterologous DNA sequence (i.e., "foreign DNA").
- native DNA sequence refers to a nucleotide sequence which is naturally found in the cell but that may have been modified from its original form.
- the pollen from the maintainer can be used to fertilize plants that are homozygous for the recessive trait, and the progeny will therefore retain their homozygous recessive condition.
- the maintainer plant containing the restoring transgene construct is propagated by self-fertilization, with the resulting seed used to produce further plants that are homozygous recessive plants and contain the restoring transgene construct.
- the maintainer plant serves as a pollen donor to the plant having the homozygous recessive trait.
- the maintainer is optimally produced from a plant having the homozygous recessive trait and which also has nucleotide sequences introduced therein which would restore the trait created by the homozygous recessive alleles.
- the restoration sequence is linked to nucleotide sequences which interfere with the function or formation of male gametes.
- the gene can operate to prevent formation of male gametes or prevent function of the male gametes by any of a variety of well-know modalities and is not limited to a particular methodology.
- this can include use of genes which express a product cytotoxic to male gametes (See for example, 5,792,853; 5,689,049; PCT/EP89/00495); inhibit product formation of another gene important to male gamete function or formation (See, U.S. Patent Nos. 5,859,341 ; 6,297,426); combine with another gene product to produce a substance preventing gene formation or function (See U.S. Patent Nos.
- genes which can impact proper development or function is included at U.S. Patent No. 6,399,856 and includes genes with inhibitory effects such as cytotoxin genes, methylase genes, and growth-inhibiting genes.
- Example of such genes include, but are not limited to diphtheria toxin A-chain gene (Czako, M. and An, G. (1991 ) "Expression of DNA coding for Diptheria toxin Chain A is toxic to plant cells" Plant Physiol. 95 687-692. and Greenfield et al PNAS 80:6853 (1983), Palmiter et al Ce// 50:435 (1987)); cell cycle division mutants such as CDC in maize (Colasanti, J., Tyers, M.
- cytotoxic genes can include, but are not limited to pectate lyase gene pelE, from Erwinia chrysanthermi (Kenn et al J. Bacteroil 168:595 (1986)); T-urf13 gene from cms-T maize mitochondrial genomes (Braun et al Plant Ce// 2:153 (1990); Dewey et al. PNAS 84:5374 (1987)); CytA toxin gene from Bacillus thuringiensis lsraeliensis that causes cell membrane disruption (McLean et al J. Bacteriol 169:1017 (1987), U.S. Patent No.
- RNAses U.S. Patent No. 5,633,441
- proteases or a genes expressing anti-sense RNA.
- a suitable gene may also encode a protein involved in inhibiting pistil development, pollen stigma interactions, pollen tube growth or fertilization, or a combination thereof.
- genes that either interfere with the normal accumulation of starch in pollen or affect osmotic balance within pollen may also be suitable.
- the DAM-methylase gene is used, discussed supra and at US Patent Nos. 5,792,852 and 5,689,049, the expression product of which catalyzes methylation of adenine residues in the DNA of the plant.
- Methylated adenines will affect cell viability and will be found only in the tissues in which the DAM-methylase gene is expressed.
- an ⁇ - amylase gene can be used with a male tissue-preferred promoter.
- the aleurone layer cells will synthesize ⁇ -amylase, which participates in hydrolyzing starch to form glucose and maltose, so as to provide the nutrients needed for the growth of the germ (J. C. Rogers and C. Milliman, J. Biol. Chem., 259 (19): 12234-12240, 1984; Rogers, J. C, J. Biol. Chem., 260: 3731 -3738, 1985).
- the ⁇ -amylase gene used can be the Zea mays ⁇ -amylase-1 gene. Young et al. "Cloning of an ⁇ -amylase cDNA from aleurone tissue of germinating maize seed" Plant Physiol. 105(2) 759-760 and GenBank accession No. L25805, Gl:426481 ). Sequences encoding ⁇ - amylase are not typically found in pollen cells, and when expression is directed to male tissue, the result is a breakdown of the energy source for the pollen grains, and repression of pollen development. One skilled in this area readily appreciates the methods described herein are applicable to any other crops which have the potential to outcross.
- the homozygous recessive condition can be maintained, while crossing it with the maintainer plant. This method can be used with any situation in which is it desired to continue the recessive condition. This results in a cost-effective system that is relatively easy to operate to maintain a population of homozygous recessive plants.
- a sporophytic gene is one which operates independently of the gametes.
- the maintainer plant When the homozygous recessive condition is one which produces male sterility by preventing male sporophyte development, the maintainer plant, of necessity, must contain a functional restoring transgene construct capable of complementing the mutation and rendering the homozygous recessive plant able to produce viable pollen.
- Linking this sporophytic restoration gene with a second functional nucleotide sequence which interferes with the function or formation of the male gametes of the plant results in a maintainer plant that produces viable pollen that only contains the recessive allele of the sporophytic gene at its native locus due to the action of the second nucleotide sequence in interfering with pollen formation or function.
- This viable pollen fraction is non-transgenic with regard to the restoring transgene construct.
- a marker gene may be provided in the construct with the restoring transgene.
- a herbicide resistant marker such as bar allows one to eliminate cells not having the restoring transgene.
- a scorable marker such as the Ds Red2 fluorescent protein
- any inadvertent transmission of the transgene can also be detected visually, and such escapes eliminated from progeny.
- many other variations in the restoring construct are available to one skilled in the art.
- a method of maintaining a homozygous recessive condition of a male sterile plant at a genetic locus in which is employed a first nucleotide sequence which is a gene critical to male fertility, a second nucleotide sequence which inhibits the function or formation of viable male gametes, an optional third nucleotide sequence which is operably linked to the first sequence and preferentially expresses the sequence in male plant cells, an optional fourth nucleotide sequence operably linked to a fourth nucleotide sequence, the fourth sequence directing expression to male gametes, and an optional fifth nucleotide sequence which is a selectable or scorable marker allowing for selection of plant cells.
- a plant which is ms45/ms45 homozygous recessive may have introduced into it a functional sporophytic Ms45 gene, and thus is male fertile.
- This gene can be linked to a gene which operates to render pollen containing the restoring transgene construct nonfunctional or prevents its formation, or which produces a lethal product in pollen, linked to the promoter directing its expression to the male gametes to produce a plant that only produced pollen containing ms45 without the restoring transgene construct.
- An example is a construct which includes the Ms45 gene, linked with a
- 5126 promoter a male tissue-preferred promoter (See U.S. Patent No. 5,750,868; 5,837,851 ; and 5,689,051 ) and further linked to the cytotoxic DAM methylase gene under control of the polygalacturonase promoter, PG47 promoter (See U.S. patent No. 5,792,853; 5,689,049) in a hemizygotic condition. Therefore the resulting plant produces pollen, but the only viable pollen results from the allele not containing the restoring Ms45/DAM methylase construct and thus contains only the ms45 gene.
- progeny produced will continue to be male sterile as a result of maintaining homozygosity for ms45.
- the progeny will also not contain the introduced restoring transgene construct.
- the Mscai gene is linked with a Mscai promoter, and further linked to the Zea mays ⁇ -amylase gene under control of the male tissue-preferred PG47 promoter.
- the scorable marker used in an embodiment is DS-RED2.
- a desirable result of the process of the invention is that the plant having the restorer nucleotide sequence may be self-fertilized, that is pollen from the plant transferred to the flower of the same plant to achieve the propagation of restorer plants.
- self fertilization it includes the situation where the plant producing the pollen is fertilized with that same plant's pollen, and the situation where two or more identical inbred plants are planted together and pollen from the identical inbred plant pollinate a separate but identical inbred plant).
- the restoring transgene construct will not be present in the pollen cells but it will be contained in 50% of the ovules (the female gamete).
- the seed resulting from the self-fertilization can be planted, and selection made for the seed having the restoring transgene construct.
- the selection process can occur by any one of many known processes; the most common where the restoration nucleotide sequence is linked to a marker gene.
- the marker can be scorable or selectable, and allows those plants produced from the seed having the restoration gene to be identified.
- the male gamete-tissue preferred promoter is inducible. Additional control is thus allowed in the process, where so desired, by providing that the plant having the restoration nucleotide sequences is constitutively male sterile.
- This type of male sterility is set forth the in U.S. Patent No. 5,859,341.
- the inducing substance In order for the plant to become fertile, the inducing substance must be provided, and the plant will become fertile. Again, when combined with the process of the invention as described supra, the only pollen produced will not contain the restoration nucleotide sequences. Further detailed description is provided below by way of instruction and illustration and is not intended to limit the scope of the invention.
- ROXY1 a member of the plant glutaredoxin family, is required for petal development in Arabidopsis thaliana (2005) Development 132, 1555-1565).
- Glutaredoxin genes are ubiquitous small heat-stable oxidoreductases that are believed to function in a wide range of cellular processes from DNA synthesis to protein folding, redox regulation of transcription and translation, and cellular signaling, among others.
- the sequences with highest similarity were regions that had 77% identity to a glutaredoxin-like protein.
- GenBank access No. XP_476652 GenBank access No. XP_476652.
- the present invention encompasses a DNA molecule having a nucleotide sequence of SEQ ID NO: SEQ ID NO: 15 ( Figure 9), or those with sequence identity, which hybridize to same under stringent conditions and fragments, and having the function of a male tissue-preferred regulatory region.
- Mscai is a male fertility gene in maize. When it is mutated, and made homozygous recessive, male sterility will result.
- An orthologue of Mscai was identified in rice.
- the rice Deleteagene population was prepared and used to screen for individuals harboring deletions of the mscai gene. (Xin Li et.al A fast neutron deletion mutagenesis-based reverse genetics system for plants. The Plant Journal Volume 27 Page 235 - August 2001 ). With this process, random deletion libraries are produced using fast neutrons to cause mutations. The libraries are screened for specific deletion mutants using polymerase chain reaction (PCR).
- PCR polymerase chain reaction
- the goal is to screen the library with one primer specific to the gene and a primer specific to the insertion element in such a way that one can discriminate between amplification of wild-type DNA from insertion DNA in large pools.
- the primers amplify both wild-type and mutant genes, but the PCR extension time is reduced in order to suppress amplification of the wild-type DNA.
- a long extension time is first used to confirm primer quality, then a shorter extension time to determine under what conditions amplification of wild-type DNA is suppressed. This time is used to screen the mega pools.
- a second round of PCR using nested primers is used to increase sensitivity.
- a motif for the redox region, CCMC, and the GSH binding region VPVVFVGGRLLG is present in the rice mscai protein as shown in Figurei 1.
- the subclone of this gene is very similar in size and sequence composition to the maize Mscai genomic clone that has been shown to complement the maize mscai mutation.
- the present invention encompasses a DNA molecule having a nucleotide sequence of SEQ ID NO: 16 (or those with sequence identity or which hybridize under stringent conditions or fragments of same) and having the function of a male tissue-preferred regulatory region.
- SEQ ID NO: 16 or those with sequence identity or which hybridize under stringent conditions or fragments of same
- a construct designated PHP27077 is made by assembling following DNA components:
- the plasmid pSB11 backbone DNA (pSB31 lacking the EcoRI fragment carrying the 35SGUS and 35SBAR genes, lshida et al., Nature Biotechnol. (1996) 14:745-750).
- This DNA backbone contains T-DNA border sequences and the replication origin from pBR322.
- the 35S:PAT gene which encodes the enzyme phosphinothricin acetyltransferase (PAT) from Streptomyces viridochomagenes (nucleotides 6- 557 from accession number A02774, Strauch et al.
- Transformation of maize mscai plants A male-sterile female which was homozygous for the msca1-ref mutant allele, (mscai) was repeatedly crossed with bulked pollen from maize Hi-type Il plants (Armstrong 1994, In: Freeling and Walbot (eds). The Maize Handbook. Springer, New York, pp 663-671 ) resulting in the introgression of this mscai allele in transformation amenable maize germplasm over multiple generations.
- the resultant source of material for transformation consisted of embryos segregating (1 :1 or 3:1 ) for mscai and allowed for both transformation directly into a homozygous mscai background and to test the genetic complementation of the mscai mutation in T 0 plants.
- /Agroibactemm-mediated transformation was performed according to Zhao et al. 1999, (United States Patent number 5,981 ,840).
- Genotyping and molecular analysis (integration and plant transcription units/PTU) of transformants were done according Cigan et al., (Sex. Plant. Reprod. 1 (2001 ) 4:135-142). Single copy, intact PTU events were identified by Southern analysis. Mscai genotyping was accomplished by PCR of the single copy events.
- a second construct, PHP27618, is essentially the same as PHP27077, but has had a frameshift introduced into the mscai gene, adding four base pairs at position 1508 of the sequence SEQ ID NO: 1_)to disrupt the putative translation of the gene.
- Single copy, intact PTU events were identified by Southern analysis.
- Mscai genotyping was done by PCR on the single copy events.
- Male fertility/sterility phenotype scores were taken at flowering. Results show that the frameshifted Mscai genomic fragment does not restore male fertility to msca1/msca1 plants which indicates that the putative translation product shown in Figure 3 is the correct translational frame for the Mscai gene. Specific results are shown below.
- PHP28154 was prepared with bases 1 -1109 of the Mscai promoter (SEQ ID NO: 15) and also included the cyan fluorescent protein (CFP) marker (Bolte et al. (2004) J. Cell Science 117: 943-54 and Kato et al. (2002) Plant Physiol 129: 913-42). Following Agrobacterium transformation (into GS3, the events were subjected to quantitative polymerase chain reaction (QPCR) of the PAT gene to determine copy number. Duplicate plants for most of the events were sent to the greenhouse. Tissue dissection from the duplicates was initiated at around the three to four leaf stage through the eight leaf stage.
- CFP cyan fluorescent protein
- the construct was prepared which included a smaller portion of the Mscai genomic sequence. This fragment included 1291 bases of the genomic Mscai , starting from position 610 to 1900 bp SEQ ID NO: 1 ( Figure 2) which corresponds to a promoter length of 522 bases, from 610 to 1132 bases of the promoter sequence in Figure 9. (SEQ ID NO: 15).
- the construct was prepared with the following components: 1.
- the plasmid pSB11 backbone DNA pSB31 lacking the EcoRI fragment carrying the 35SGUS and 35SBAR genes, lshida et al., Nature Biotechnol. (1996) 14:745-750). This DNA backbone contains T-DNA border sequences and the replication origin from pBR322.
- the PG47PRO:ZM-AA1 gene which contains alpha-amylase 1 coding region from Zea mays.
- LTP2:DS-RED2 (ALT1 ) which contains red florescence coding region (a variant of Discosoma sp. red fluorescent protein (DsRed), from Clontech mutated to remove BstEII site, codon sequence unchanged) driven by LTP2 promoter, supra. Plants were transformed with PHP27612 as described supra, into mscai sterile mutants. The introduction of the construct did not complement the mutation and the plants remained sterile, indicating that there are regulatory elements outside of this 1291 basepair fragment that are required for normal Mscai biological function.
- DsRed Discosoma sp. red fluorescent protein
- nucleotide sequences which map to the short arm of chromosome 7 of the Zea mays genome, at the same site as the Mscai gene, and its alleles are genes critical to male fertility in plants, that is, are necessary for fertility of a plant, or, when mutated from the sequence found in a fertile plant, cause sterility in the plant.
- the invention achieves at least all of its objectives.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201070229A EA201070229A1 (en) | 2007-08-03 | 2007-08-03 | MSCA1 NUCLEOTIC SEQUENCE, AFFECTING MALE PLANT FERTILITY, AND METHOD OF THEIR APPLICATION |
MX2010001347A MX2010001347A (en) | 2007-08-03 | 2007-08-03 | Msca1 nucleotide sequences impacting plant male fertility and method of using same. |
BRPI0722195-9A BRPI0722195B1 (en) | 2007-08-03 | 2007-08-03 | METHODS FOR MAINTENANCE OF A PLANT RECESSIVE HOMOZYGOTE STATE |
CN200780100132A CN101802201A (en) | 2007-08-03 | 2007-08-03 | Influence the MSCA1 nucleotide sequence of plant male fertility and the method for using it |
EP07813738A EP2173883A1 (en) | 2007-08-03 | 2007-08-03 | Msca1 nucleotide sequences impacting plant male fertility and method of using same |
EP12168569.7A EP2631243A3 (en) | 2007-08-03 | 2007-08-03 | Msca1 nucleotide sequences impacting plant male fertility and method of using same |
PCT/US2007/075157 WO2009020458A1 (en) | 2007-08-03 | 2007-08-03 | Msca1 nucleotide sequences impacting plant male fertility and method of using same |
CA2695530A CA2695530C (en) | 2007-08-03 | 2007-08-03 | Msca1 nucleotide sequences impacting plant male fertility and method of using same |
ARP070105365A AR064085A1 (en) | 2007-08-03 | 2007-11-30 | SEQUENCES OF NUCLEOTIDOS MSCA1 AFFECTING MALE VEGETABLE FERTILITY AND METHOD TO USE THE SAME |
CL2008000072A CL2008000072A1 (en) | 2007-08-03 | 2008-01-10 | Msca1 nucleotide sequences affecting male fertility, vector and host cell that comprise it; and method to impact on male fertility in a plant. |
ZA2010/00532A ZA201000532B (en) | 2007-08-03 | 2010-01-25 | Msca1 nucleotide sequences impacting plant male fertility and method of using same |
ARP150102856A AR101779A2 (en) | 2007-08-03 | 2015-09-07 | SEQUENCES OF MSCA1 NUCLEOTIDES AFFECTING MALE VEGETABLE FERTILITY AND METHOD FOR USING THE SAME |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2007/075157 WO2009020458A1 (en) | 2007-08-03 | 2007-08-03 | Msca1 nucleotide sequences impacting plant male fertility and method of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009020458A1 true WO2009020458A1 (en) | 2009-02-12 |
Family
ID=39284733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/075157 WO2009020458A1 (en) | 2007-08-03 | 2007-08-03 | Msca1 nucleotide sequences impacting plant male fertility and method of using same |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP2173883A1 (en) |
CN (1) | CN101802201A (en) |
AR (2) | AR064085A1 (en) |
BR (1) | BRPI0722195B1 (en) |
CA (1) | CA2695530C (en) |
CL (1) | CL2008000072A1 (en) |
EA (1) | EA201070229A1 (en) |
MX (1) | MX2010001347A (en) |
WO (1) | WO2009020458A1 (en) |
ZA (1) | ZA201000532B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013138399A1 (en) * | 2012-03-14 | 2013-09-19 | E. I. Du Pont De Nemours And Company | Improving agronomic characteristics of plants through abph2 |
WO2014039815A2 (en) * | 2012-09-06 | 2014-03-13 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising male fertility sequences |
WO2014152447A2 (en) * | 2013-03-15 | 2014-09-25 | Pioneer Hi-Bred International, Inc. | Cloning and use of the ms9 gene from maize |
US9803215B2 (en) | 2007-08-03 | 2017-10-31 | Pioneer Hi-Bred International, Inc. | MSCA1 nucleotide sequences impacting plant male fertility and method of using same |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102477091B (en) * | 2010-11-30 | 2013-11-13 | 中国科学院遗传与发育生物学研究所 | Rice male sterile protein and coding gene and application thereof |
CN105755009A (en) * | 2012-11-09 | 2016-07-13 | 深圳市作物分子设计育种研究院 | Fertility gene and application thereof |
UA123765C2 (en) * | 2014-09-26 | 2021-06-02 | Піонір Хай-Бред Інтернешнл, Інк. | Wheat ms1 polynucleotides, polypeptides, and methods of use |
GB2552657A (en) * | 2016-07-29 | 2018-02-07 | Elsoms Dev Ltd | Wheat |
CN113088524B (en) * | 2021-04-09 | 2023-03-24 | 武汉市农业科学院 | Separation clone and application of male nuclear sterility gene Brams of pakchoi |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352605A (en) | 1983-01-17 | 1994-10-04 | Monsanto Company | Chimeric genes for transforming plant cells using viral promoters |
US5689049A (en) * | 1994-12-08 | 1997-11-18 | Pioneer Hi-Bred International, Inc. | Transgenic plant and method for producing male sterility using anther specific promoter 5126 |
WO1998059061A1 (en) * | 1997-06-23 | 1998-12-30 | Pioneer Hi-Bred International, Inc. | Male tissue-preferred regulatory region and method of using same |
WO2003008540A2 (en) * | 2001-06-22 | 2003-01-30 | Syngenta Participations Ag | Abiotic stress responsive polynucleotides and polypeptides |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3710511A (en) | 1971-04-21 | 1973-01-16 | Univ Illinois | Procedures for use of genic male sterility in production of commercial hybrid maize |
US3861709A (en) | 1973-07-12 | 1975-01-21 | Amsted Ind Inc | Shiftable fifth wheel construction |
NL8200523A (en) | 1982-02-11 | 1983-09-01 | Univ Leiden | METHOD FOR TRANSFORMING IN VITRO PLANT PROTOPLASTS WITH PLASMIDE DNA. |
EP0160692A1 (en) | 1983-11-03 | 1985-11-13 | DE WET, Johannes Martenis Jacob | Method for the transfer of exogenous genes in plants using pollen as a vector |
ATE93542T1 (en) | 1984-12-28 | 1993-09-15 | Plant Genetic Systems Nv | RECOMBINANT DNA THAT CAN BE INTRODUCED INTO PLANT CELLS. |
US4918006A (en) | 1985-07-01 | 1990-04-17 | E. I. Du Pont De Nemours And Company | Gene coding for insecticidal crystal protein |
US4654465A (en) | 1985-07-18 | 1987-03-31 | Agracetus | Genic male-sterile maize |
US5268463A (en) | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
US4727219A (en) | 1986-11-28 | 1988-02-23 | Agracetus | Genic male-sterile maize using a linked marker gene |
US5015580A (en) | 1987-07-29 | 1991-05-14 | Agracetus | Particle-mediated transformation of soybean plants and lines |
EP0275069A3 (en) | 1987-01-13 | 1990-04-25 | DNA PLANT TECHNOLOGY CORPORATION (under the laws of the state of Delaware) | Pollen-mediated gene transformation in plants |
CN87100603A (en) | 1987-01-21 | 1988-08-10 | 昂科公司 | Vaccines against melanoma |
US5728926A (en) | 1988-02-03 | 1998-03-17 | Pioneer Hi-Bred International, Inc. | Antisense gene systems of pollination control for hybrid seed production |
NZ227835A (en) | 1988-02-03 | 1992-09-25 | Paladin Hybrids Inc | Antisense gene systems of pollination control for hybrid seed production |
US6198023B1 (en) | 1988-02-03 | 2001-03-06 | Pioneer Hi-Bred International, Inc. | Molecular methods of hybrid seed production |
US6198026B1 (en) | 1988-02-03 | 2001-03-06 | Pioneer Hi-Bred International, Inc. | Molecular methods of hybrid seed production |
US5356799A (en) | 1988-02-03 | 1994-10-18 | Pioneer Hi-Bred International, Inc. | Antisense gene systems of pollination control for hybrid seed production |
ATE112314T1 (en) | 1988-05-17 | 1994-10-15 | Lubrizol Genetics Inc | PLANT UBIQUITIN PROMOTOR SYSTEM. |
GB8901674D0 (en) | 1989-01-26 | 1989-03-15 | Ici Plc | Regulation of plant gene expression |
DE69034190T2 (en) | 1989-02-02 | 2006-02-23 | Pioneer Hi-Bred International, Inc. | MOLECULAR PROCESSES FOR THE MULTIPLICATION OF HYBRID SEEDS |
KR920701453A (en) | 1989-03-17 | 1992-08-11 | 미리엄 디. 멕코나헤이 | External regulation of gene expression |
US5633441A (en) | 1989-08-04 | 1997-05-27 | Plant Genetic Systems, N.V. | Plants with genetic female sterility |
US5550318A (en) | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US6297426B1 (en) | 1990-06-12 | 2001-10-02 | Pioneer Hi-Bred International, Inc. | Methods of mediating female fertility in plants |
US5824524A (en) | 1990-06-12 | 1998-10-20 | Pioneer Hi-Bred International, Inc. | Nucleotide sequences mediating fertility and method of using same |
US5478369A (en) | 1990-06-12 | 1995-12-26 | Pioneer Hi-Bred International, Inc. | Nucleotide sequences mediating male fertility and method of using same |
JP3325022B2 (en) | 1990-06-18 | 2002-09-17 | モンサント カンパニー | Increased starch content in plants |
ATE398679T1 (en) | 1992-07-07 | 2008-07-15 | Japan Tobacco Inc | METHOD FOR TRANSFORMING A MONOCOTYLEDON PLANT |
ATE147434T1 (en) | 1992-07-09 | 1997-01-15 | Pioneer Hi Bred Int | POLLEN SPECIFIC POLYGALACTURONASE GENE FROM CORN |
US5792852A (en) | 1992-11-16 | 1998-08-11 | Cancer Research Fund Of Contra Costa | Polynucleotides encoding modified antibodies with human milk fat globule specificity |
US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
US5789156A (en) | 1993-06-14 | 1998-08-04 | Basf Ag | Tetracycline-regulated transcriptional inhibitors |
US5470359A (en) | 1994-04-21 | 1995-11-28 | Pioneer Hi-Bred Internation, Inc. | Regulatory element conferring tapetum specificity |
US6013859A (en) | 1994-07-14 | 2000-01-11 | Pioneer Hi-Bred International, Inc. | Molecular methods of hybrid seed production |
US5795753A (en) | 1994-12-08 | 1998-08-18 | Pioneer Hi-Bred International Inc. | Reversible nuclear genetic system for male sterility in transgenic plants |
US5962769A (en) | 1995-06-07 | 1999-10-05 | Pioneer Hi-Bred International, Inc. | Induction of male sterility in plants by expression of high levels of avidin |
US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
GB9710475D0 (en) | 1997-05-21 | 1997-07-16 | Zeneca Ltd | Gene silencing |
WO1999053050A1 (en) | 1998-04-08 | 1999-10-21 | Commonwealth Scientific And Industrial Research Organisation | Methods and means for obtaining modified phenotypes |
AU5788299A (en) | 1998-08-28 | 2000-03-21 | Pioneer Hi-Bred International, Inc. | Seed-preferred promoters from (end) genes |
WO2000015791A1 (en) | 1998-09-10 | 2000-03-23 | Pioneer Hi-Bred International, Inc. | Ecdysone receptors and methods for their use |
WO2000055315A1 (en) | 1999-03-16 | 2000-09-21 | Pioneer Hi-Bred International, Inc. | Sf3 promoter and methods of use |
US7365185B2 (en) * | 2000-07-19 | 2008-04-29 | Monsanto Technology Llc | Genomic plant sequences and uses thereof |
CA2401495A1 (en) | 2000-02-28 | 2001-09-07 | Yale University | Methods and compositions to reduce or eliminate transmission of a transgene |
US7517975B2 (en) * | 2000-09-26 | 2009-04-14 | Pioneer Hi-Bred International, Inc. | Nucleotide sequences mediating male fertility and method of using same |
US6956118B2 (en) | 2001-02-08 | 2005-10-18 | Pioneer Hi-Bred International, Inc. | Promoter sequences providing male tissue-preferred expression in plants |
TW525063B (en) | 2001-09-03 | 2003-03-21 | Via Tech Inc | General accelerated graphic port interface system and the operation method thereof |
US7491813B2 (en) * | 2005-12-07 | 2009-02-17 | Monsanto Technology Llc | Promoter polynucleotides identified from Zea mays for use in plants |
US9515229B2 (en) | 2010-09-21 | 2016-12-06 | Cree, Inc. | Semiconductor light emitting devices with optical coatings and methods of making same |
-
2007
- 2007-08-03 CN CN200780100132A patent/CN101802201A/en active Pending
- 2007-08-03 WO PCT/US2007/075157 patent/WO2009020458A1/en active Application Filing
- 2007-08-03 MX MX2010001347A patent/MX2010001347A/en active IP Right Grant
- 2007-08-03 EP EP07813738A patent/EP2173883A1/en not_active Withdrawn
- 2007-08-03 EA EA201070229A patent/EA201070229A1/en unknown
- 2007-08-03 EP EP12168569.7A patent/EP2631243A3/en not_active Withdrawn
- 2007-08-03 CA CA2695530A patent/CA2695530C/en not_active Expired - Fee Related
- 2007-08-03 BR BRPI0722195-9A patent/BRPI0722195B1/en not_active IP Right Cessation
- 2007-11-30 AR ARP070105365A patent/AR064085A1/en not_active Application Discontinuation
-
2008
- 2008-01-10 CL CL2008000072A patent/CL2008000072A1/en unknown
-
2010
- 2010-01-25 ZA ZA2010/00532A patent/ZA201000532B/en unknown
-
2015
- 2015-09-07 AR ARP150102856A patent/AR101779A2/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352605A (en) | 1983-01-17 | 1994-10-04 | Monsanto Company | Chimeric genes for transforming plant cells using viral promoters |
US5689049A (en) * | 1994-12-08 | 1997-11-18 | Pioneer Hi-Bred International, Inc. | Transgenic plant and method for producing male sterility using anther specific promoter 5126 |
WO1998059061A1 (en) * | 1997-06-23 | 1998-12-30 | Pioneer Hi-Bred International, Inc. | Male tissue-preferred regulatory region and method of using same |
WO2003008540A2 (en) * | 2001-06-22 | 2003-01-30 | Syngenta Participations Ag | Abiotic stress responsive polynucleotides and polypeptides |
Non-Patent Citations (15)
Title |
---|
BORTIRI ET AL: "Advances in maize genomics: the emergence of positional cloning", CURRENT OPINION IN PLANT BIOLOGY, QUADRANT SUBSCRIPTION SERVICES, GB, vol. 9, no. 2, 2 February 2006 (2006-02-02), pages 164 - 171, XP005306208, ISSN: 1369-5266 * |
CHAUBAL RAJ ET AL: "The transformation of anthers in the msca1 mutant of maize.", PLANTA (BERLIN), vol. 216, no. 5, 13 November 2002 (2002-11-13), pages 778 - 788, XP002478549, ISSN: 0032-0935 * |
DATABASE EMBL [online] 17 May 2003 (2003-05-17), "OGPAX10TV ZM_0.7_1.5_KB Zea mays genomic clone ZMMBMa0355B20, DNA sequence.", XP002494685, retrieved from EBI accession no. EMBL:CC343065 Database accession no. CC343065 * |
DATABASE EMBL [online] 22 December 2006 (2006-12-22), "Zea mays chromosome 7 clone ZMMBBb-226D18; ZMMBBb0226D18, *** SEQUENCING IN PROGRESS ***, 13 unordered pieces.", XP002478555, retrieved from EBI accession no. EMBL:AC195322 Database accession no. AC195322 * |
DATABASE EMBL [online] 22 December 2006 (2006-12-22), "Zea mays chromosome 7 clone ZMMBBb-226D18; ZMMBBb0226D18, *** SEQUENCING IN PROGRESS ***, 13 unordered pieces.", XP002494686, retrieved from EBI accession no. EMBL:AC195322 Database accession no. AC195322 * |
DATABASE EMBL [online] 31 May 2001 (2001-05-31), "Oryza sativa Japonica Group genomic DNA, chromosome 7, BAC clone:OJ1048_C10.", XP002478553, retrieved from EBI accession no. EMBL:AP003704 Database accession no. AP003704 * |
DATABASE Geneseq [online] 2 June 2005 (2005-06-02), "Rice abiotic stress responsive polynucleotide SEQ ID NO:1602.", XP002478552, retrieved from EBI accession no. GSN:ACL27646 Database accession no. ACL27646 * |
DATABASE Geneseq [online] 2 June 2005 (2005-06-02), "Rice stress-regulated promoter SEQ ID NO:14975.", XP002494684, retrieved from EBI accession no. GSN:ACL36412 Database accession no. ACL36412 * |
DATABASE UniProt [online] 1 October 2003 (2003-10-01), "Glutaredoxin-C9.", XP002478554, retrieved from EBI accession no. UNIPROT:Q7XIZ1 Database accession no. Q7XIZ1 * |
HESSEL, D AND LAUTER, N.: "Dual testcross QTL analysis: a solution to the current rate-limiting steps of positionally cloning QTL in maize", 49TH ANNUAL MAIZE GENETICS CONFERENCE, 2007, St. Charles, Illinois, 22.-25.03.2007, pages 130, XP002478550, Retrieved from the Internet <URL:http://shrimp1.gdcb.iastate.edu/mmdocs/2007Program.pdf> [retrieved on 20080428] * |
ROUHIER NICOLAS ET AL: "Genome-wide analysis of plant glutaredoxin systems", JOURNAL OF EXPERIMENTAL BOTANY, vol. 57, no. 8, 2006, pages 1685 - 1696, XP002478546, ISSN: 0022-0957 * |
See also references of EP2173883A1 * |
TRIMNELL, M. R. ET AL.: "New male-sterile mutant allele of Ms22", MAIZE GENETICS COOPERATION NEWSLETTER, vol. 75, 2001, pages 31, XP002478548, Retrieved from the Internet <URL:http://www.maizegdb.org/mnl/75/63trimnell.html> [retrieved on 20080428] * |
WEST, D.P. AND ALBERTSEN, M. C.: "Three new male-sterile genes", MAIZE GENETICS COOPERATION NEWSLETTER, vol. 59, 1985, pages 87, XP002478547, Retrieved from the Internet <URL:http://www.maizegdb.org/mnl/59/128west.html> [retrieved on 20080428] * |
WILLIAMS, M. ET AL.: "Map-based cloning of the nsf1 (nicosulfuron susceptible 1) gene of maize", 48TH ANNUAL MAIZE GENETICS CONFERENCE, 2006, Pacific Grove, Canada, 09.-12.03.2006, XP002478551, Retrieved from the Internet <URL:http://www.maizegdb.org/cgi-bin/displayrefrecord.cgi?id=974457> [retrieved on 20080428] * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9803215B2 (en) | 2007-08-03 | 2017-10-31 | Pioneer Hi-Bred International, Inc. | MSCA1 nucleotide sequences impacting plant male fertility and method of using same |
WO2013138399A1 (en) * | 2012-03-14 | 2013-09-19 | E. I. Du Pont De Nemours And Company | Improving agronomic characteristics of plants through abph2 |
WO2014039815A2 (en) * | 2012-09-06 | 2014-03-13 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising male fertility sequences |
WO2014039815A3 (en) * | 2012-09-06 | 2014-06-19 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising male fertility sequences |
AU2013312392B2 (en) * | 2012-09-06 | 2017-08-24 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising male fertility sequences |
EA029014B1 (en) * | 2012-09-06 | 2018-01-31 | Пайонир Хай-Бред Интернэшнл, Инк. | Compositions and methods comprising male fertility sequences |
AU2013312392C1 (en) * | 2012-09-06 | 2018-03-08 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising male fertility sequences |
AU2019240727B2 (en) * | 2012-09-06 | 2021-02-25 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising male fertility sequences |
US11377668B2 (en) | 2012-09-06 | 2022-07-05 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising male fertility sequences |
WO2014152447A2 (en) * | 2013-03-15 | 2014-09-25 | Pioneer Hi-Bred International, Inc. | Cloning and use of the ms9 gene from maize |
WO2014152447A3 (en) * | 2013-03-15 | 2015-01-08 | Pioneer Hi-Bred International, Inc. | Cloning and use of the ms9 gene from maize |
Also Published As
Publication number | Publication date |
---|---|
AR101779A2 (en) | 2017-01-11 |
EA201070229A1 (en) | 2010-08-30 |
AR064085A1 (en) | 2009-03-11 |
BRPI0722195A2 (en) | 2012-10-09 |
CL2008000072A1 (en) | 2009-02-06 |
EP2631243A2 (en) | 2013-08-28 |
EP2173883A1 (en) | 2010-04-14 |
EP2631243A3 (en) | 2013-11-20 |
CN101802201A (en) | 2010-08-11 |
CA2695530C (en) | 2016-07-05 |
ZA201000532B (en) | 2012-01-25 |
CA2695530A1 (en) | 2009-02-12 |
BRPI0722195B1 (en) | 2018-01-30 |
MX2010001347A (en) | 2010-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7919676B2 (en) | Msca1 nucleotide sequences impacting plant male fertility and method of using same | |
US8178750B2 (en) | Nucleotide sequences mediating male fertility and method of using same | |
US9803215B2 (en) | MSCA1 nucleotide sequences impacting plant male fertility and method of using same | |
EP2295585A1 (en) | Nucleotide sequences mediating plant male fertility and method of using same | |
CA2695530C (en) | Msca1 nucleotide sequences impacting plant male fertility and method of using same | |
US8648228B2 (en) | MSCA1 nucleotide sequences impacting plant male fertility and method of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780100132.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07813738 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2007813738 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007813738 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 636/DELNP/2010 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2695530 Country of ref document: CA Ref document number: MX/A/2010/001347 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12010500277 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201070229 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201002260 Country of ref document: UA |
|
ENP | Entry into the national phase |
Ref document number: PI0722195 Country of ref document: BR Kind code of ref document: A2 Effective date: 20100201 |